L. Daly

908 total citations
20 papers, 746 citations indexed

About

L. Daly is a scholar working on Reproductive Medicine, Molecular Biology and Oncology. According to data from OpenAlex, L. Daly has authored 20 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in L. Daly's work include Ovarian cancer diagnosis and treatment (8 papers), Glycosylation and Glycoproteins Research (3 papers) and Reproductive System and Pregnancy (3 papers). L. Daly is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Glycosylation and Glycoproteins Research (3 papers) and Reproductive System and Pregnancy (3 papers). L. Daly collaborates with scholars based in United States and United Kingdom. L. Daly's co-authors include Robert C. Bast, John T. Soper, Daniel L. Clarke‐Pearson, Andrew Berchuck, Feng Xu, Robert Woolas, David Oram, Subramanian Ramakrishnan, Yanhong Yu and Verda J. Hunter and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

L. Daly

20 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Daly United States	13	418	236	177	118	115	20	746
Mark G. Federici United States	12	238 0.6×	201 0.9×	228 1.3×	77 0.7×	120 1.0×	14	635
J. M. G. Bonfrer Netherlands	14	186 0.4×	255 1.1×	202 1.1×	90 0.8×	103 0.9×	25	670
Michel Préfontaine Canada	17	289 0.7×	179 0.8×	134 0.8×	84 0.7×	48 0.4×	42	734
M. Amneus United States	10	273 0.7×	354 1.5×	139 0.8×	245 2.1×	78 0.7×	18	854
Svend A. Engelholm Denmark	17	201 0.5×	177 0.8×	262 1.5×	145 1.2×	30 0.3×	37	693
Antonella Pietragalla Italy	17	210 0.5×	262 1.1×	270 1.5×	119 1.0×	71 0.6×	36	693
S. Goodrich United States	9	511 1.2×	180 0.8×	142 0.8×	161 1.4×	56 0.5×	14	737
Gianni Amunni Italy	20	449 1.1×	261 1.1×	358 2.0×	175 1.5×	118 1.0×	55	1.2k
J. Carmichael United Kingdom	16	374 0.9×	299 1.3×	635 3.6×	178 1.5×	59 0.5×	24	987
Pierre‐Alexandre Just France	17	308 0.7×	415 1.8×	269 1.5×	222 1.9×	116 1.0×	45	1.1k

Countries citing papers authored by L. Daly

Since Specialization

Citations

This map shows the geographic impact of L. Daly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Daly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Daly more than expected).

Fields of papers citing papers by L. Daly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Daly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Daly. The network helps show where L. Daly may publish in the future.

Co-authorship network of co-authors of L. Daly

This figure shows the co-authorship network connecting the top 25 collaborators of L. Daly. A scholar is included among the top collaborators of L. Daly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Daly. L. Daly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Chappell, Sally, L. Daly, Kevin Morgan, et al.. (2006). Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. 1(3). 103–106. 15 indexed citations

2.

Bast, Robert C., Lajos Pusztai, Billie‐Jo Kerns, et al.. (1998). Coexpression of the HER-2 Gene Product, pl85 ^HER-2 , and Epidermal Growth Factor Receptor, pl70 ^EGF-R , on Epithelial Ovarian Cancers and Normal Tissues. Hybridoma. 17(4). 313–321. 32 indexed citations

3.

Martell, Robert E., et al.. (1998). OVX1 and CEA in Patients with Colon Carcinoma, Colon Polyps and Benign Colon Disorders. The International Journal of Biological Markers. 13(3). 145–149. 3 indexed citations

4.

Bepler, Gerold, Kwun M. Fong, B. E. Johnson, et al.. (1998). Association of chromosome 11 locus D11S12 with histology, stage, and metastases in lung cancer.. PubMed. 22(1). 14–9. 20 indexed citations

5.

Woolas, Robert, Mark R. Conaway, Fengji Xu, et al.. (1995). Combinations of Multiple Serum Markers Are Superior to Individual Assays for Discriminating Malignant from Benign Pelvic Masses. Gynecologic Oncology. 59(1). 111–116. 90 indexed citations

6.

Xu, Fengji, Yinhua Yu, L. Daly, et al.. (1994). OVX1 as a marker for early stage endometrial carcinoma. Cancer. 73(7). 1855–1858. 9 indexed citations

7.

Woolas, Robert, Feng Xu, Yanhong Yu, et al.. (1993). Elevation of Multiple Serum Markers in Patients With Stage I Ovarian Cancer. JNCI Journal of the National Cancer Institute. 85(21). 1748–1751. 158 indexed citations

8.

Xu, Feng, Yan Yu, L. Daly, et al.. (1993). OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.. Journal of Clinical Oncology. 11(8). 1506–1510. 38 indexed citations

9.

O'Briant, Kathy, Verda J. Hunter, L. Daly, et al.. (1992). Ha-ras polymorphisms in epithelial ovarian cancer. Gynecologic Oncology. 45(3). 299–302. 4 indexed citations

10.

Daly, L., John Ferguson, Vera Hárs, et al.. (1992). Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen.. Journal of Clinical Oncology. 10(7). 1057–1065. 10 indexed citations

11.

Boyer, C., Russel E. Kaufman, Kathy O'Briant, et al.. (1991). Expression and amplification of the HER-2/ neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines. American Journal of Obstetrics and Gynecology. 165(3). 640–646. 57 indexed citations

12.

Bast, Robert C., A A Epenetos, B Dhokia, et al.. (1991). Coordinate elevation of serum markers in ovarian cancer but not in benign disease. Cancer. 68(8). 1758–1763. 45 indexed citations

13.

Xu, Feng, Subramanian Ramakrishnan, L. Daly, et al.. (1991). Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. American Journal of Obstetrics and Gynecology. 165(5). 1356–1362. 67 indexed citations

14.

Xu, Feng, Subramanian Ramakrishnan, L. Daly, et al.. (1991). Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. American Journal of Obstetrics and Gynecology. 165(4). 1356–1362. 49 indexed citations

15.

Hunter, Verda J., L. Daly, Michael J. Helms, et al.. (1990). The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction. American Journal of Obstetrics and Gynecology. 163(4). 1164–1167. 44 indexed citations

16.

Soper, John T., et al.. (1990). Preoperative serum tumor-associated antigen levels in women with pelvic masses.. PubMed. 75(2). 249–54. 57 indexed citations

17.

McCormick, P. Aiden, et al.. (1986). PEPTIC ULCER IN RHEUMATOID ARTHRITIS-INTRINSIC OR RELATED TO DRUG THERAPY?. Lara D. Veeken. 25(4). 342–344. 26 indexed citations

18.

Hayes, Alan, et al.. (1983). Anthropometric standards for Irish newborn.. PubMed. 76(2). 60, 62, 64–6 passim. 9 indexed citations

19.

Moriarty, M., et al.. (1981). A randomised study of dietary intake in patients undergoing radiation therapy.. PubMed. 74(2). 39–42. 6 indexed citations

20.

D’Souza, David, L. Daly, & R. D. Thornes. (1980). Cyclophosphamide, prednisone, staphage lysate and warfarin in disseminated breast cancer.. PubMed. 73(10). 385–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact